CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade TransMedics Group Inc - TMDX CFD

86.17
3.89%
Market Trading Hours* (UTC) Opens on Thursday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.28
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024818 %
Charges from full value of position ($-4.72)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.024818%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.002596 %
Charges from full value of position ($0.49)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.002596%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.7
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 82.94
Open 84.59
1-Year Change 98.75%
Day's Range 83.23 - 86.75
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Nov 5, 2024 82.94 -1.51 -1.79% 84.45 84.72 82.55
Nov 4, 2024 84.83 3.07 3.75% 81.76 85.19 81.56
Nov 1, 2024 82.35 -0.27 -0.33% 82.62 85.37 80.78
Oct 31, 2024 81.89 0.39 0.48% 81.50 82.87 79.84
Oct 30, 2024 81.89 -5.82 -6.64% 87.71 87.82 81.45
Oct 29, 2024 88.45 -2.66 -2.92% 91.11 96.15 85.43
Oct 28, 2024 126.13 -3.02 -2.34% 129.15 133.95 126.05
Oct 25, 2024 125.09 1.64 1.33% 123.45 126.43 120.67
Oct 24, 2024 121.92 1.45 1.20% 120.47 123.43 118.95
Oct 23, 2024 118.55 -3.52 -2.88% 122.07 122.95 116.53
Oct 22, 2024 122.89 -1.16 -0.94% 124.05 125.83 121.56
Oct 21, 2024 124.35 -2.20 -1.74% 126.55 127.63 121.81
Oct 18, 2024 126.51 -0.68 -0.53% 127.19 131.65 126.46
Oct 17, 2024 127.08 -3.00 -2.31% 130.08 131.70 125.75
Oct 16, 2024 129.84 -1.31 -1.00% 131.15 131.99 126.15
Oct 15, 2024 131.70 -3.38 -2.50% 135.08 135.58 131.15
Oct 14, 2024 134.13 -1.82 -1.34% 135.95 135.95 133.45
Oct 11, 2024 135.08 0.03 0.02% 135.05 137.27 134.85
Oct 10, 2024 135.70 -0.25 -0.18% 135.95 135.95 133.32
Oct 9, 2024 137.11 -1.34 -0.97% 138.45 139.04 134.83

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

TransMedics Group, Inc. Company profile

About TransMedics Group Inc

TransMedics Group, Inc. is a commercial-stage medical technology company. It is focused on developing organ transplant therapy for end-stage organ failure patients across multiple disease states. The Company has designed and developed organ care system (OCS) a portable organ perfusion, optimization and monitoring system that utilizes customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It has developed three OCS products, one for each of lung, heart and liver transplantations. Its OCS clinical programs include OCS Heart EXPAND Trial, OCS Heart EXPAND Continued Access Protocol, or CAP, Trial and OCS Heart PROCEED II Trials. Its organ care system (OCS) technology platform to perfuse donor organs with warm, oxygenated, nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, TransMedics Group Inc revenues increased 18% to $30.3M. Net loss increased 54% to $44.2M. Revenues reflect OCS Lung net revenue segment increase of 72% to $10.7M, OCS Heart net revenue segment increase of 25% to $17.7M, United States segment increase of 14% to $21.9M, All other countries segment increase of 31% to $8.4M.

Industry: Advanced Medical Equipment & Technology (NEC)

200 Minuteman Road
ANDOVER
MASSACHUSETTS 01810
US

News

FOMC and BOE preview: further rate cuts expected

Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.

14:14, 5 November 2024

RBA meeting preview: No change to policy expected as inflation fight continues

The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.

13:35, 4 November 2024

US elections: Trump leads the polls, but tariff talk spooks investors

As the US elections get closer we look at how Trump’s tariff plans could affect markets.

15:02, 22 October 2024

Gold markets to trade

Last week, we explored the basic fundamental and technical approaches to gold trading. Having covered the key price drivers of this critical asset and how you might use data to trade it, you’re ready to assess the conditions for entry. But there are a range of markets that can effectively give you exposure to gold.

08:00, 21 October 2024

US earnings seasons off to a solid start as focus shifts to tech giants

The US earnings season has started on a positive note, with major banks exceeding expectations and boosting market sentiment.Key themes for the sector include investments in artificial intelligence, capital expenditure returns, and consumer trends in advertising and e-commerce. The S&P 500 continues to climb, driven by strong earnings, resilient economic growth, and the potential for interest rate cuts. Keep an eye on significant support and resistance levels as the market tests new record highs.

14:31, 17 October 2024

ECB Preview: cooling growth and inflation call for another rate cut

Markets are convinced the European Central Bank (ECB) will cut rates by 25 basis points again at Thursday’s meeting.

12:41, 16 October 2024

Australian labour force data forecast to reveal stable jobs market

Australia's labour market remained stable in September 2024, with the unemployment rate forecast to hold at 4.2%, supported by a 25,200 person rise in employment. Despite the economy teetering on the edge of recession, strong hiring trends persist, challenging market economists' predictions.

07:41, 15 October 2024

People also watch

Oil - Crude

71.62 Price
-0.200% 1D Chg, %
Long position overnight fee 0.0088%
Short position overnight fee -0.0307%
Overnight fee time 22:00 (UTC)
Spread 0.030

XRP/USD

0.55 Price
+6.860% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01168

BTC/USD

75,885.30 Price
+9.420% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Gold

2,659.16 Price
-3.100% 1D Chg, %
Long position overnight fee -0.0180%
Short position overnight fee 0.0098%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 650,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading